2016版中国脑血管病诊治指南与共识
上QQ阅读APP看书,第一时间看更新

参考文献

[1]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[2]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J].中华神经科杂志,2015,48(4):258-273.
[3]饶明俐.中国脑血管病防治指南[M].北京:人民卫生出版社,2007.
[4]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153.
[5]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010,43(2):154-160.
[6]中华医学会神经病学分会脑血管病学组“卒中一级预防指南”撰写组.中国卒中一级预防指南2010[J].中华神经科杂志,2011,44(4):282-288.
[7]中华医学会神经病学分会脑血管病学组缺血性脑血管病血管内介入诊疗指南撰写组.中国缺血性脑血管病血管内介入诊疗指南[J].中华神经科杂志,2011,43(12):863-869.
[8]中华医学会神经病学分会脑血管学组卒中诊治指南编写组.中国颅内静脉系统血栓形成诊断和治疗指南[J].中华神经科杂志,2012,45(11):818-823.
[9]杨杰,刘鸣.急性缺血性脑卒中临床实践指南的现状及趋势[J].中国神经精神疾病杂志,2002,28(5):400,附1,附2.
[10]刘鸣.临床实践指南意义、建立方法和评价[J].中国卒中杂志,2006,1(1):33-36.
[11]刘鸣,杨杰,王一平.对循证指南制定方法与临床应用的新思考[J].中国循证医学杂志,2009,9(2):127-128.
[12]刘鸣.关于急性缺血性脑卒中诊治指南中有关分型、分期治疗问题的答复[J].中华全科医师杂志,2011,10(2):151-152.
[13]卫茂玲,刘鸣.中国临床指南循证制定的方法学现状分析[J].中国循证医学杂志,2013,13(8):927-932.
[14]刘鸣,张苏明,郝子龙,等.中国急性缺血性卒中诊治指南2010版的制定及解读[J].中华神经科杂志,2011,44(6):369-374.
[15]World Stroke Organization Stroke Guidelines Sub-committee.Clinical practice guideline development handbook for stroke care[R/OL].June 2009.[2011-04-14].http://www.world-stroke.org/guidelines.asp.
[16]刘鸣.系统评价、Meta-分析及在神经疾病的临床应用[J].中华神经科杂志,2001,34(6):369-371.
[17]Hao Z,Liu M,Counsell C,et al.Fibrinogen depleting agents for acute ischaemic stroke[J/CD].Cochrane Database Syst Rev,2012(3):CD000091.
[18]Feng S,Yang Q,Liu M,et al.Edaravone for acute ischaemic stroke[J/CD].Cochrane Database Syst Rev,2011(12):CD007230.
[19]Wu B,Liu M,Liu H,et al.Meta-analysis of traditional Chinese patentmedicine for ischemic stroke[J].Stroke,2007,38(6):1973-1979.
[20]Zhang SH,Liu M,Asplund K,et al.Acupuncture for acute stroke[J/CD].Cochrane Database Syst Rev,2005(2):CD003317.
[21]何莎,刘鸣,曾泉滔,等.中国急性脑卒中随机对照试验证据现状与趋势分析[J].中华医学杂志,2013,93(43):3433-3437.
[22]Jauch EC,Saver JL,Adams HP Jr,etal.Guidelines for the earlymanagementof patientswith acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947.
[23]European Stroke Organisation(ESO)Executive Committee,ESO W riting Committee.Guidelines for management of ischaemic stroke and transient ischaemic attack 2008[J].Cerebrovasc Dis,2008,25(5):457-507.
[24]Uchiyama S.Japanese guidelines for themanagement of stroke 2009[J].Nihon Ronen Igakkai Zasshi,2011,48(6):633-636.
[25]Steiner T,Al-Shahi Salman R,Beer R,etal.European Stroke Organisation(ESO)guidelines for themanagementof spontaneous intracerebral hemorrhage[J].Int JStroke,2014,9(7):840-855.
[26]刘鸣,何俐.神经疾病领域循证医学的应用概述[J].中华神经科杂志,2000,33(6):368-370.
[27]European Stroke Organization(ESO)Excutive Committee.Update guidelines January 2009 new elements[EB/OL].http://www/eso-stroke.org/eso-stroke/education/guidelines.html.
[28]Asimos AW.Guidelines for extending the tissue plasminogen activator treatmentwindow for ischemic stroke[J].Stroke,2009,40(11):e633.
[29]Adams HP Jr,del Zoppo GJ,Alberts MJ,et al.Guidelines for the earlymanagement of adultswith ischemic stroke:a guideline from the American Heart Association/American Stroke Association Stroke Council,Clinical Cardiology Council,Cardiovascular Radiology and Intervention Council,and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists[J].Stroke,2007,38(5):1655-1711.